View Post

Mesothelioma Victims Center Now Urges a US Navy Veteran with Mesothelioma or Asbestos Exposure Lung Cancer to Call Them

In In The News by Barbara Jacoby

Source: Mesothelioma Victims Center From: prnewswire.com Mesothelioma Victims Center Now Urges a US Navy Veteran with Mesothelioma or Asbestos Exposure Lung Cancer to Call Them for Direct Access to Attorney Erik Karst to Discuss the Value of Their Compensation Claim—Especially If the Veteran Was Stationed at Norfolk-Pearl Harbor or San Diego The Mesothelioma Victims Center’s number one goal is making …

View Post

Immunotherapy for lung cancer: Researchers working to broaden its reach

In Clinical Trials by Barbara Jacoby

By: Scott Merville From: mdanderson.org Immunotherapy drugs have produced promising results in cancers like melanoma and leukemia, yet the drugs only work for 20 percent of lung cancer patients. MD Anderson researchers are working to change that. Immunotherapy drugs that free the immune system to attack cancer have provided durable responses for about 20 percent of lung cancer patients, which …

View Post

Heat Biologics Presents Interim Phase 2 Lung Cancer Data on HS-110 + Nivolumab

In Clinical Trials by Barbara Jacoby

At ASCO-SITC Clinical Immuno-Oncology Symposium From: digitaljournal.com – Preliminary data suggests the addition of HS-110 to Nivolumab may restore responsiveness to treatment after tumor progression on prior checkpoint inhibitor therapy – Median overall survival not yet reached with median follow up of 14.4 months in Cohort A – Improved survival observed in patients with low CD8+ “cold” tumor at baseline …

View Post

Racial disparities in US cancer deaths are shrinking, study finds

In In The News by Barbara Jacoby

Posted By: CNN Wire From: wtvr.com Racial disparities in cancer deaths between black and white patients in the United States are receding — but more progress is needed to completely close the gap for some cancer types and age groups, according to a new study. Among men, the overall cancer death rate was 47% higher for blacks than for whites …

View Post

Breast cancer drugs could help treat therapy-resistant lung cancers

In Clinical Trials by Barbara Jacoby

Source: PTI | London From: theweek.in A class of drugs used to treat certain breast cancers could help fight lung cancers A class of drugs used to treat certain breast cancers could help fight lung cancers that have become resistant to targeted therapies, according to a study conducted in mice. The study, published in the journal Cell Reports, found that …

View Post

New insight into why malaria drugs work against some cancers could boost drug development

In Clinical Trials by Barbara Jacoby

By: Arlene Weintraub From: fiercebiotech.com There are currently about 20 clinical trials underway evaluating a class of malaria drugs known as chloroquines in several tumor types, including breast cancer, lung cancer and multiple solid tumors, according to ClinicalTrials.gov. Anti-malarial drugs, in fact, have long been of interest in the oncology community because of their ability to shrink some cancers. But …

View Post

New virus could help destroy cancer

In In The News by Barbara Jacoby

By: Chiara Townley From: medicalnewstoday.com A new study examines the behavior of a cancer-killing virus that fits tumor cells perfectly and leaves healthy cells intact. Cancer is a chronic disease that kills millions of people worldwide. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is likely to be responsible for more …

View Post

Weight-loss drug could fight resistant lung cancer

In In The News by Barbara Jacoby

Posted by National University of Singapore From: futurity.org New research could pave the way for using versions of an existing drug to keep lung cancer cells from becoming drug-resistant. Researchers have discovered that a key enzyme in lipid metabolism controls the response to a class of targeted drugs called tyrosine kinase inhibitors (TKIs) in lung cancer. Cells use nutrients such …

View Post

Lung cancer risk drops substantially within five years of quitting, new research finds

In In The News by Barbara Jacoby

Source: Vanderbilt University Medical Center From: sciencenewsdaily.com Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer. That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.i These are the main findings of a new analysis of the landmark …

View Post

Lung cancer destroyed with tea leaf nanoparticles

In In The News by Barbara Jacoby

By: Ana Sandoiu From: medicalnewstoday.com A new study has shown that lung cancer cells can be destroyed using nanoparticles derived from tea leaves. These tiny particles, called “quantum dots,” are 400 times thinner than a human hair, and producing them from tea leaves is safe and non-toxic. More and more research has been focusing on the potential uses of nanoparticles for …